| Literature DB >> 31447805 |
Anusuya Nagaraj1, Suja Samiappan1.
Abstract
In tclass="Chemical">he present study, for tEntities:
Keywords: Azadirachta indica; anti-inflammation; antibacterial; antioxidant; biomimetic; hydroxyapatite
Year: 2019 PMID: 31447805 PMCID: PMC6692563 DOI: 10.3389/fmicb.2019.01757
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Total phenolics (mg GAE/g) and flavonoids (mg CCE/g) in ethanolic extract of A. indica (AI). The experiments were performed individually in six replicates and achieved results were stated as mean ± standard deviation. The data were statistically evaluated by one-way ANOVA following Tukey’s post hoc multiple comparison test. The statistical variance among the experimental groups was measured as significant at p < 0.05. The columns with different alphabets were significant within the respective study.
Figure 2FT-IR spectrum of (A) hydroxyapatite (HA), (B) ethanolic extract of A. indica (AI), and (C) hydroxyapatite–A. indica (HA-AI) composite. XRD pattern of (D) HA and (E) HA-AI composite.
Figure 3Zeta potential of (A) hydroxyapatite (HA) and (B) hydroxyapatite–A. indica (HA-AI) composite. DLS pattern of (C) HA and (D) HA-AI composite.
Figure 4SEM images of (A) hydroxyapatite (HA) and (B) hydroxyapatite–A. indica (HA-AI) composite. HR-TEM image of (C) HA and (D) HA-AI composite. SEM-EDX pattern of (E) HA, (F) AI, and (G) HA-AI composite.
Elemental analysis of hydroxyapatite (HA), A. indica (AI), and HA-AI composite by SEM-EDX.
| Elements | HA | AI | HA-AI composite |
|---|---|---|---|
| Ca (%) | 46.91 | – | 34.70 |
| P (%) | 32.14 | – | 28.88 |
| O (%) | 19.52 | 11.07 | 14.19 |
| C (%) | – | 83.64 | 19.31 |
| Cl (%) | – | 2.41 | 1.07 |
| K (%) | – | 1.09 | |
| Total (%) | 98.57 | 98.21 | 98.15 |
Figure 5ABTS and DPPH radical scavenging potentials of hydroxyapatite–A. indica (HA-AI) composite. The experiments were performed individually in six replicates and achieved results were stated as mean ± standard deviation. The data were statistically evaluated by one-way ANOVA following Tukey’s post hoc multiple comparison test. The statistical variance among the experimental groups was measured as significant at p < 0.05. The columns with different alphabets were significant within the respective study.
Figure 6SEM images of S. aureus (ATCC 700699) and E. coli (ATCC 10536) as untreated (control) and treated with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of hydroxyapatite–A. indica (HA-AI) composite.
Figure 7Assessment of protective efficacy of hydroxyapatite (HA) and hydroxyapatite–A. indica (HA-AI) composite on LPS-induced death of RAW 264.7 cells by cell viability assays. Biocompatibility of (A) HA and (B) HA-AI composite on cell viability determined by MTT assay. Protective efficacy of HA against LPS-induced cell death determined by (C) MTT and (D) live/dead dual staining assays. Protective efficacy of HA-AI composite against LPS-induced cell death determined by (E) MTT and (F) live/dead dual staining assays. (G) Bright-fielding microscopic images representing the protective efficacy of HA-AI composite on LPS-induced cell death. The images were taken at magnification of 400×. (H) Live/dead dual staining microscopic images representing the protective efficacy of HA-AI composite on LPS-induced cell death. The scale bar is 200 μm. Green and red colors represent the live and dead cells, respectively. The experiments were performed individually in six replicates and achieved results were stated as mean ± standard deviation. The data were statistically evaluated by one-way ANOVA following Tukey’s post hoc multiple comparison test. The statistical variance among the experimental groups was measured as significant at p < 0.05. The columns with different alphabets were significant within the respective study.
Figure 8Assessment of protective efficacy of hydroxyapatite–A. indica (HA-AI) composite on LPS-induced oxidative and inflammatory stress in RAW 264.7 cells. (A) Dose-dependent protective efficacy of HA-AI composite on LPS-induced intracellular ROS generation by DCFH-DA staining. (B) Phase contrast and fluorescent microscopic images depicting the protective efficacy of HA-AI composite on LPS-induced intracellular ROS generation by DCFH-DA staining. The scale bar is 100 μm. (C) Dose-dependent protective efficacy of HA-AI composite on LPS-induced nitrite generation. (D) Dose-dependent protective efficacy of HA-AI composite on LPS-induced lipid peroxidation. (E–G) Dose-dependent protective efficacy of HA-AI composite on LPS-induced detrimental effect on antioxidant enzymes, i.e. SOD, GSH, and CAT. (H,I) Dose-dependent protective efficacy of HA-AI composite on LPS-induced inflammatory cytokines (TNF-α and IL-6) by ELISA. (J–M) Dose-dependent protective efficacy of HA-AI composite on LPS-induced inflammation regulatory genes (TNF-α, IL-6, iNOS, and COX-2) by real-time PCR analysis. The experiments were performed individually in six replicates and achieved results were stated as mean ± standard deviation. The data were statistically evaluated by one-way ANOVA following Tukey’s post hoc multiple comparison test. The statistical variance among the experimental groups was measured as significant at p < 0.05. The columns with different alphabets were significant within the respective study.
Figure 9Assessment of restoring efficacy of hydroxyapatite–A. indica (HA-AI) composite on LPS-induced depletion of mitochondrial membrane potential (MMP) in RAW 264.7 cells by rhodamine 123 staining. (A) Dose-dependent restoring efficacy of HA-AI composite on LPS-induced depletion of MMP. (B) Phase contrast and fluorescent microscopic images depicting the restoring efficacy of HA-AI composite on LPS-induced depletion of MMP. The scale bar is 100 μm. The experiments were performed individually in six replicates and achieved results were stated as mean ± standard deviation. The data were statistically evaluated by one-way ANOVA following Tukey’s post hoc multiple comparison test. The statistical variance among the experimental groups was measured as significant at p < 0.05. The columns with different alphabets were significant within the respective study.
Figure 10Assessment of protective efficacy of hydroxyapatite–A. indica (HA-AI) composite on LPS-induced nuclear damage and apoptosis in RAW 264.7 cells. (A) Phase contrast and fluorescent microscopic images depicting the protective efficacy of HA-AI composite on LPS-induced nuclear damage by DAPI staining. (B) Dose-dependent protective efficacy of HA-AI composite on LPS-induced apoptosis by DAPI staining. (C–E) Dose-dependent restoring efficacy of HA-AI composite on LPS-induced depletion of caspases (3/7, 8, and 9). The experiments were performed individually in six replicates and achieved results were stated as mean ± standard deviation. The data were statistically evaluated by one-way ANOVA following Tukey’s post hoc multiple comparison test. The statistical variance among the experimental groups was measured as significant at p < 0.05. The columns with different alphabets were significant within the respective study.